Clinical Trials Directory

Trials / Completed

CompletedNCT03754842

Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans

Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans - A Randomized, Placebo-controlled, Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
55 Years – 80 Years
Healthy volunteers
Accepted

Summary

Successful skeletal muscle regeneration depends on a functional pool of muscle stem cells, termed satellite cells (SC). SC are in a quiescent state throughout adulthood, but undergo multiple cycles of proliferation and self-renewal in response to muscle damage. During aging, there is a loss of SC quiescence, and SC more readily enter an ageing-state impairing their function. Animal studies have revealed a common denominator for increasing SC function and activity, namely Sirtuin activation. Natural stimulators of Sirtuins includes Nicotinamide Riboside (NR) (a Nicotinamide adenine dinucleotide (NAD+) precursor) and the polyphenol Pterostilbene (PT). In this study, we aim to investigate if NR+PT supplementation will promote skeletal muscle regeneration after muscle damage in elderly humans by enhanced recruitment of SC.

Detailed description

14 days after start of placebo or NR/PT (500/100 mg twice daily) supplementation a muscle damage will induced in the m. vastus lat. by electric stimulation combined with eccentric work in a dynamometer. Muscle biopsies will be collected at 2 hours, 2, 8 and 30 days post damage and placebo or NR/PT supplementation will continue for the whole study period (45 days).

Conditions

Interventions

TypeNameDescription
OTHERPlacebo (twice daily)Matching placebo
OTHERNicotinamide Riboside/Pterostilbene (500 mg/100 mg twice daily)Elysium Basis TM, Elysium Health, Inc., NY, USA

Timeline

Start date
2019-02-12
Primary completion
2020-09-01
Completion
2020-09-01
First posted
2018-11-27
Last updated
2020-11-05

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03754842. Inclusion in this directory is not an endorsement.